Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II randomized double-blind study of recombinant zoster vaccine SCTV04C in healthy adults
CTR20250316Phase 2Active
- Sponsor
- Sinocelltech Group Limited
- Start
- Mar 2025
- Modality
- Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of SCTV04C in herpes zoster (HZ), Varicella zoster infection, sponsored by Sinocelltech Group Limited. Started Mar 2025; status: active.
02
Drugs
SCTV04C
03
Conditions
herpes zoster (HZ)Varicella zoster infection
Beyond the preview
Go deeper on CTR20250316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250316.